Skip to main content
Clinical Trials/IRCT20240106060632N1
IRCT20240106060632N1
Recruiting
Phase 2

Determining the effect of local use of injectable vancomycin in preventing exit site infection in children with peritoneal dialysis

Mashhad University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Exit site infection of peritoneal dialysis.
Sponsor
Mashhad University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Receiving Peritoneal Dialysis
  • 2 Months to 18 years old
  • Not having a history of Vancomycin Allergy
  • Absence of Underlying Dermatologic Diseases based on initial clinical evaluation
  • Informed Consent
  • Not Receiving Systemic Antibiotics in last month

Exclusion Criteria

  • Sensitivity to Vancomycin
  • Younger than 2 Month old

Outcomes

Primary Outcomes

Not specified

Similar Trials